INCREASE HISTONE METHYLATION FOR THE TREATMENT OF H3.3 K27M MUTANT BRAINSTEM GLIOMAS

被引：0

作者：

Hashizume, Rintaro ^{[1
]}

Ihara, Yuichiro ^{[1
]}

Andor, Noemi ^{[1
]}

Chen, Xiaoyue ^{[3
]}

Lerner, Robin ^{[1
]}

Huang, Xi ^{[1
]}

Tom, Maxwell ^{[1
]}

Solomon, David ^{[2
]}

Mueller, Sabine ^{[1
]}

Petritsch, Claudia ^{[1
]}

Zhang, Zhiguo ^{[3
]}

Gupta, Nalin ^{[1
]}

Waldman, Todd ^{[2
]}

James, David ^{[1
]}

机构：

[1] Univ Calif San Francisco, San Francisco, CA 94143 USA

[2] Georgetown Univ, Washington, DC USA

[3] Mayo Clin, Rochester, MN USA

来源：

NEURO-ONCOLOGY | 2014年 / 16卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

HG-058

引用

页码：54 / 54

页数：1

共 50 条

[21] Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of chromatin marks
Chaouch, Amel
Berlandi, Johannes
Chen, Carol C. L.
Frey, Felice
Badini, Shireen
Harutyunyan, Ashot S.
Chen, Xiao
Krug, Brian
Hebert, Steven
Jeibmann, Astrid
Lu, Chao
Kleinman, Claudia L.
Hasselblatt, Martin
Lasko, Paul
Shirinian, Margret
Jabado, Nada
MOLECULAR CELL, 2021, 81 (23) : 4876 - +
[22] Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Voon, Hsiao P. J.
Hii, Linda
Garvie, Andrew
Udugama, Maheshi
Krug, Brian
Russo, Caterina
Chueeh, Anderly C.
Daly, Roger J.
Morey, Alison
Bell, Toby D. M.
Turner, Stephen J.
Rosenbluh, Joseph
Daniel, Paul
Firestein, Ron
Mann, Jeffrey R.
Collas, Philippe
Jabado, Nada
Wong, Lee H.
GENOME BIOLOGY, 2023, 24 (01)
[23] Novel and shared neoantigen for glioma T cell therapy derived from histone 3 variant H3.3 K27M mutation
Hou, Yafei
Kohanbash, Gary
Okada, Kaori
Shrivastav, Shruti
Smith-Cohn, Matthew
Nicolaides, Theodore
Mueller, Sabine
Carcaboso, Angel Montero
Pollack, Ian F.
Okada, Hideho
CANCER IMMUNOLOGY RESEARCH, 2016, 4 (01)
[24] NOVEL AND SHARED NEOANTIGEN FOR GLIOMA T CELL THERAPY DERIVED FROM HISTONE 3 VARIANT H3.3 K27M MUTATION
Kohanbash, Gary
Okada, Kaori
Liu, Shuming
Lin, Yi
Shrivastav, Shruti
Nicolaides, Theodore
Mueller, Sabine
Pollack, Ian
Carcaboso, Angel
Hou, Yafei
Okada, Hideho
NEURO-ONCOLOGY, 2016, 18 : 67 - 67
[25] Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Hsiao P. J. Voon
Linda Hii
Andrew Garvie
Maheshi Udugama
Brian Krug
Caterina Russo
Anderly C. Chüeh
Roger J. Daly
Alison Morey
Toby D. M. Bell
Stephen J. Turner
Joseph Rosenbluh
Paul Daniel
Ron Firestein
Jeffrey R. Mann
Philippe Collas
Nada Jabado
Lee H. Wong
Genome Biology, 24
[26] K27M MUTATION IN HISTONE H3.3 DEFINES A DIFFERENT DISEASE IN PEDIATRIC AND YOUNG ADULT HIGH GRADE GLIOMAS WITH UNIQUE CLINICAL FEATURES: THE FLORENTINE EXPERIENCE WITH LITERATURE REVIEW
Lucchesi, M.
Scoccianti, S.
Guidi, M.
Facchini, L.
Farina, S.
Fonte, C.
Favre, C.
Genitori, L.
Sardi, I.
NEURO-ONCOLOGY, 2016, 18 : 64 - 64
[27] Knock-down of H3.3 K27M mutant protein in DIPG cells delays, but does not abrogate, tumor growth in vivo
Silveira, Andre B.
Zhu, Xiaoyan
Qu, Chunxu
Baker, Suzanne
CANCER RESEARCH, 2015, 75
[28] K27M MUTATION IN HISTONE H3.3 DEFINES A DIFFERENT DISEASE IN PEDIATRIC AND YOUNG ADULT HIGH GRADE GLIOMAS WITH UNIQUE CLINICAL FEATURES: THE FLORENTINE EXPERIENCE WITH LITERATURE REVIEW
Lucchesi, Maurizio
Guidi, Milena
Giunti, Laura
Buccoliero, Anna Maria
Fonte, Carla
Farina, Silvia
Favre, Claudio
Genitori, Lorenzo
Sardi, Iacopo
NEURO-ONCOLOGY, 2016, 18 : 53 - 54
[29] Gain of function in the K27M mutant in Histone 3.3 promotes the proliferation in a mouse glial cell line
Miyai, Masafumi
Tomita, Hiroyuki
Hara, Akira
CANCER SCIENCE, 2018, 109 : 1127 - 1127
[30] TARGETING THE HISTONE H3.3-K27M MUTATION FOR THE TREATMENT OF DIFFUSE INTRINSIC PONTINE GLIOMAS
Hashizume, Rintaro
Ihara, Yuichiro
Huang, Xi
Lu Yu-Jen
Tom, Maxwell
Mueller, Sabine
Gupta, Nalin
Solomon, David
Waldman, Todd
Zhang, Zhiguo
James, David
NEURO-ONCOLOGY, 2013, 15 : 45 - 45

← 1 2 3 4 5 →